Carmoterol clinical trials
Also written CHF 4226.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How each study uses carmoterol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2008 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses carmoterol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2Chiesi Farmaceutici S.p.A.NCT00782535Written as CHF 4226 pMDIHow we know
- Dose Finding Study of CHF 4226 for Treating Patients With COPDCompletedPhase 2Chiesi Farmaceutici S.p.A.NCT00605891Written as carmoterol (CHF 4226)How we know
- Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPDCompletedPhase 2Chiesi Farmaceutici S.p.A.NCT00640484Written as carmoterol (CHF 4226)How we know
- Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy VolunteersCompletedPhase 1Chiesi Farmaceutici S.p.A.NCT00777595Written as CHF 4226 pMDIHow we know
Codes
What other systems call carmoterol · ClinicalTrials.gg INT003629
- MeSH (NLM) C074413carmoterolOne source NLM
- UNII (FDA) 9810NUL4D1CARMOTEROLConfirmed FDA, NLM, Wikidata
- Wikidata Q25104123carmoterolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171749CarmoterolOne source FDA
- DrugBank DB15784One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C074413 | carmoterol | One source NLM |
| UNII (FDA) | 9810NUL4D1 | CARMOTEROL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q25104123 | carmoterol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171749 | Carmoterol | One source FDA |
| DrugBank | DB15784 | — | One source Wikidata |
Also registered as carmoterol hydrochloride (UNII 0WLO9P0V75).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.